CIK 0000874716 · Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010393723
- Phone
- 2075560300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | FENNELL GEORGE Executive Vice President | Option exercise | +706 | $141.60 | $100K | 11,139 |
| 2026-11-10 | FENNELL GEORGE Executive Vice President | Option exercise | +560 | $178.26 | $100K | 11,699 |
| 2026-11-10 | FENNELL GEORGE Executive Vice President | Option exercise | +483 | $206.94 | $100K | 12,182 |
| 2026-11-10 | FENNELL GEORGE Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −706 | 0 | ||
| 2026-11-10 | FENNELL GEORGE Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −560 | 0 | ||
| 2026-11-10 | FENNELL GEORGE Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −483 | 0 |
Page 1 of 1 · 6 trades